-
1
-
-
0009612394
-
Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus: Minnesota and North Dakota, 1997-1999
-
Centers for Disease Control and Prevention. 1999. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus: Minnesota and North Dakota, 1997-1999. Morb. Mortal. Wkly. Rep. 48:707-710.
-
(1999)
Morb. Mortal. Wkly. Rep.
, vol.48
, pp. 707-710
-
-
-
2
-
-
0037024849
-
Staphylococcus aureus resistant to vancomycin-United States, 2002
-
Centers for Disease Control and Prevention. 2002. Staphylococcus aureus resistant to vancomycin-United States, 2002. Morb. Mortal. Wkly. Rep. 51:565-567.
-
(2002)
Morb. Mortal. Wkly. Rep.
, vol.51
, pp. 565-567
-
-
-
3
-
-
0030841073
-
A methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
-
Hiramatsu, K., H. Hanaki, T. Ino, K. Yabuta, T. Oguri, and F. C. Tenover. 1997. A methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrob. Chemother. 40:135-146.
-
(1997)
J. Antimicrob. Chemother.
, vol.40
, pp. 135-146
-
-
Hiramatsu, K.1
Hanaki, H.2
Ino, T.3
Yabuta, K.4
Oguri, T.5
Tenover, F.C.6
-
4
-
-
0024450068
-
A new macrolide, TE-031 (A-56268), in treatment of experimental Legionnaire's disease
-
Kohno, S., H. Koga, K. Yamaguchi, M. Masaki, Y. Inoue, Y. Dotsu, Y. Masuyama, T. Hayashi, M. Hirota, A. Saito, and K. Hara. 1989. A new macrolide, TE-031 (A-56268), in treatment of experimental Legionnaire's disease. J. Antimicrob. Chemother. 24:397-405.
-
(1989)
J. Antimicrob. Chemother.
, vol.24
, pp. 397-405
-
-
Kohno, S.1
Koga, H.2
Yamaguchi, K.3
Masaki, M.4
Inoue, Y.5
Dotsu, Y.6
Masuyama, Y.7
Hayashi, T.8
Hirota, M.9
Saito, A.10
Hara, K.11
-
5
-
-
0032551901
-
Staphylococcus aureus infections
-
Lowy, F. D. 1998. Staphylococcus aureus infections. N. Engl. J. Med. 339:520-532.
-
(1998)
N. Engl. J. Med.
, vol.339
, pp. 520-532
-
-
Lowy, F.D.1
-
6
-
-
0034018950
-
In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against staphylococci and enterococci, including vancomycin-intermediate and -resistant strains
-
Rybak, M. J., E. Hershberger, T. Moldvan, and R. G. Grucz. 2000. In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against staphylococci and enterococci, including vancomycin-intermediate and -resistant strains. Antimicrob. Agents Chemother. 44:1062-1066.
-
(2000)
Antimicrob. Agents Chemother.
, vol.44
, pp. 1062-1066
-
-
Rybak, M.J.1
Hershberger, E.2
Moldvan, T.3
Grucz, R.G.4
-
7
-
-
0026039436
-
Clinical evaluation of teicoplanin fluorescence polarization immunoassay
-
Rybak, M. J., E. M. Bailey, and V. N. Reddy. 1991. Clinical evaluation of teicoplanin fluorescence polarization immunoassay. Antimicrob. Agents Chemother. 35:1586-1590.
-
(1991)
Antimicrob. Agents Chemother.
, vol.35
, pp. 1586-1590
-
-
Rybak, M.J.1
Bailey, E.M.2
Reddy, V.N.3
-
8
-
-
0031034572
-
Role of coagulase in a murine model of hematogenous pulmonary infection by intravenous injection of Staphylococcus aureus enmeshed in agar beads
-
Sawai, T., K. Tomono, K. Yanagihara, Y. Yamamoto, M. Kaku, Y. Hirakata, H. Koga, T. Tashiro, and S. Kohno. 1997. Role of coagulase in a murine model of hematogenous pulmonary infection by intravenous injection of Staphylococcus aureus enmeshed in agar beads. Infect. Immun. 65:466-471.
-
(1997)
Infect. Immun.
, vol.65
, pp. 466-471
-
-
Sawai, T.1
Tomono, K.2
Yanagihara, K.3
Yamamoto, Y.4
Kaku, M.5
Hirakata, Y.6
Koga, H.7
Tashiro, T.8
Kohno, S.9
-
9
-
-
0033580208
-
Emergence of vancomycin resistance in Staphylococcus aureus
-
Smith, T. L., M. L. Pearson, K. R. Wilcox, C. Cruz, M. V. Lancaster, B. Robinson-Dunn, F. C. Tenover, M. J. Zervos, J. D. Band, E. White, and W. R. Jarvis. 1999. Emergence of vancomycin resistance in Staphylococcus aureus. N. Engl. J. Med. 340:493-501.
-
(1999)
N. Engl. J. Med.
, vol.340
, pp. 493-501
-
-
Smith, T.L.1
Pearson, M.L.2
Wilcox, K.R.3
Cruz, C.4
Lancaster, M.V.5
Robinson-Dunn, B.6
Tenover, F.C.7
Zervos, M.J.8
Band, J.D.9
White, E.10
Jarvis, W.R.11
-
10
-
-
0036173450
-
In vitro antibacterial activities of DQ-113, a potent quinolone, against clinical isolates
-
Tanaka, M., E. Yamazaki, M. Chiba, K. Yoshihara, T. Akasaka, M. Takemura, and K. Sato. 2002. In vitro antibacterial activities of DQ-113, a potent quinolone, against clinical isolates. Antimicrob. Agents Chemother. 46:904-908.
-
(2002)
Antimicrob. Agents Chemother.
, vol.46
, pp. 904-908
-
-
Tanaka, M.1
Yamazaki, E.2
Chiba, M.3
Yoshihara, K.4
Akasaka, T.5
Takemura, M.6
Sato, K.7
-
11
-
-
0035928419
-
Linezolid resistance in a clinical isolate of Staphylococcus aureus
-
Tsiodras S., H. S. Gold, G. Sakoulas, G. M. Eliopoulos, C. Wennersten, L. Venkataraman, R. C. Moellering, and M. J. Ferraro. 2001. Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 358:207-208.
-
(2001)
Lancet
, vol.358
, pp. 207-208
-
-
Tsiodras, S.1
Gold, H.S.2
Sakoulas, G.3
Eliopoulos, G.M.4
Wennersten, C.5
Venkataraman, L.6
Moellering, R.C.7
Ferraro, M.J.8
-
12
-
-
0036783660
-
Efficacy of linezolid against methicillin-resistant or vancomycin-insensitive Staphylococcus aureus in a model of hematogenous pulmonary infection
-
Yanagihara K., Y. Kaneko, T. Sawai, Y. Miyazaki, K. Tsukamoto, Y. Hirakata, K. Tomono, J. Kadota, T. Tashiro, I. Murata, and S. Kohno. 2002. Efficacy of linezolid against methicillin-resistant or vancomycin-insensitive Staphylococcus aureus in a model of hematogenous pulmonary infection. Antimicrob. Agents Chemother. 46:3288-3291.
-
(2002)
Antimicrob. Agents Chemother.
, vol.46
, pp. 3288-3291
-
-
Yanagihara, K.1
Kaneko, Y.2
Sawai, T.3
Miyazaki, Y.4
Tsukamoto, K.5
Hirakata, Y.6
Tomono, K.7
Kadota, J.8
Tashiro, T.9
Murata, I.10
Kohno, S.11
|